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ABSTRACT 
The relationship between hearing loss and Alzheimer’s disease has been studied 
for many years. Previous studies have shown a negative correlation between the two. In 
our study, we investigated the relationship between the strength of the auditory radiation 
connections and the severity of cognitive decline. To do so, we assessed probabilistic 
tractography using DTI data of the primary auditory pathway. Further, we assessed the 
level of cognition using the Alzheimer's Disease Assessment Scale-Cog to determine the 
relationship between the auditory connections assessed in each patient and that patient’s 
level of cognitive decline. We found that FA and AD were positively associated with 
cognitive decline.   
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Introduction 
 Alzheimer’s disease is a degenerative disease that has high prevalence worldwide. 
The prevalence of its death toll continues to increase, unlike other top killers which 
continually decrease [1]. In the United States, the disease was only responsible for 1 in 
100,000 deaths in 1980 which climbed to 25 out of 100,000 deaths by 2014 [1]. A study 
in 2013 showed that Alzheimer’s disease afflicted 13% of Americans over 65. When 
including those only over 85, this statistic increased to 43% [2]. Further, Alzheimer’s was 
the fourth leading cause of death in the United States [2]. In 2017, it was reported that 
approximately 6.08 million Americans had either clinical Alzheimer’s disease or mild 
cognitive impairment, a figure that is expected to grow to 15.0 million by 2060 [3]. This 
prevalence is also high worldwide. However, it is difficult to obtain data from all 
countries, especially developing regions. One study was able to estimate that in 2006, 
about 24.3 million people were afflicted with dementia and there was about one new case 
every 7 seconds [4]. Due to its large affect, many studies have researched risk factors 
associated with the disease. One such factor is hearing loss. 
The association between hearing loss and Alzheimer's disease has been discussed 
for decades. In 1986, an observation study enrolled 156 Alzheimer’s cases and cited 
hearing loss as foreshadowing cognitive dysfunction [5]. In 1989, after controlling for 
age, sex, and education status, they reported that hearing loss was significantly and 
independently linked with severity of cognitive dysfunction in an Alzheimer’s case-
control study [5]. A magnetic resonance brain image study indicated hearing loss 
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correlated with accelerated atrophy of the whole brain, especially the right temporal lobe 
[6]. While there are many studies that have reported an association between hearing loss 
and Alzheimer’s disease, dementia, and cognitive dysfunction, it is still unknown what 
mechanisms promote this correlation and whether this correlation is causal.  
However, there are many studies that show an increased risk of Alzheimer's due 
to hearing loss. One study shows that age related hearing loss increases a person’s risk of 
Alzheimer’s by 3.57 fold [7]. Another study found that mild hearing loss increases a 
person’s risk of Alzheimer’s by 1.9, that occupational hearing loss increases that risk by 
1.7, and that severe hearing loss increases that risk by 4.9 [8]. In another study, 
individuals who reported moderate hearing had a 1.4 increased risk of Alzheimer's while 
poor hearing individuals had a 1.6 increased risk [9]. Instead of reporting the increased 
risk, one study reported the differences in the incidence rate of the disease. The overall 
incidence rate was 2.18. The incidence rate for people with bilateral hearing impairment 
was 3.84 while the incidence rate for unspecified hearing impairment was 2.35 [10]. A 
study focusing on age related hearing loss found that the regional variation in hearing 
impairment explained 36% of the regional variation in dementia. Further, it found the 
effects of age-related hearing loss on dementia to be significant in both men and women 
[11].  
 There have been hypotheses to account for the increased risks and incidence rates 
of Alzheimer’s disease. One of the most major hypotheses is that hearing loss causes a 
loss of cognitive function which promotes Alzheimer’s. Hearing loss is understood to 
cause poor cognitive function because it causes the hearing impaired to place more effort 
in listening, which is proven to be cognitively taxing. Further, it increases cognitive load 
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and thereby exhausts compensatory cognitive reallocation [12]. One study proved that 
greater hearing loss was significantly associated with lower scores on the Digital Signal 
Substitution Test after adjustment for demographic factors and medical history (DSST 
score difference of −1.5 [95% confidence interval: −2.9 to −0.23] per 10 dB of hearing 
loss) [13]. Further, when use of a hearing aid was added, there was a positive association 
with cognitive functioning (DSST score difference of 7.4 [95% confidence interval: 
−0.62 to 15.4]) [13]. With a decrease in cognitive function, Alzheimer’s is more likely to 
appear.  
Further, there are other possible accounts. It has been hypothesized that the brain 
structure and function is changed due to hearing loss and increases the risk of 
Alzheimer’s [8]. There is a correlation between hearing loss and loss of brain volume. 
These changes may account for Alzheimer’s incidence. Other researchers suggest that the 
effects of hearing loss on an individual’s life increase the risk of Alzheimer’s. For 
example, hearing loss may cause social isolation in the elderly. Since there is a 
relationship between poor social communication and dementia, this is also a possible 
explanation [11]. The relationship between hearing loss and Alzheimer’s disease remains 
unclear. 
Memory, specifically, has been found to be influenced by hearing loss. Though 
there is little research on this relationship, one study of mice revealed that induced 
hearing loss was associated with memory decline [14]. In the study, following a noise 
exposure, which created moderate to severe hearing loss, a deficit in spatial and learning 
memory was seen [14]. This deficit was correlated with the degree of hearing loss and 
associated with a decrease of neurogenesis in the hippocampus [14].  
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 Diffusion Tensor Imaging (DTI) is a technique used to examine the integration of 
axonal white matter in the brain. This technique allows examining of the auditory 
radiation, the transmission from the medial genicular nucleus to the primary auditory 
cortex which is the final part of the pathway from the cochlea to the cerebral cortex. This 
final transmission completes the auditory pathway in order to successfully perceive 
sound. Although the auditory radiation can be assessed by probabilistic tractography 
using DTI data, it is not clear whether the auditory radiation is influenced in Alzheimer’s 
disease.  In this study we examined the auditory radiation in Alzheimer’s disease, using 
probabilistic tractography on DTI data. Specifically, we tested the association between 
the integrity of the auditory radiation and cognitive decline assessed by Alzheimer's 
Disease Assessment Scale-Cog (ADAS-Cog). 
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Methods 
 DTI data were obtained from ADNI, along with demographic and Pittsburgh 
Sleep Quality. Samples from 288 individuals (72.52±7.10, 130 females and 155 males) 
contained DTI and ADAS13 data. The analyses in this study were approved by the 
Institutional Review Board of the University of Mississippi (14x-244). ADAS13 
questions are listed in appendix 1. 
The DTI series had 41 volumes of noncolinear directions as well as 5 volumes 
without diffusion weighting (TR = 7200ms, TE = 56ms, matrix = 232 x 232 x 160) with 
2mm^3 isotropic resolution. 
Image processing was conducted using the Functional Magnetic Resonance 
Imaging of the Brain Software Library (FSL version 5.1; Oxford, United Kingdom; 
http://fsl.fmrib.ox.ac.uk/fsl). Eddy-current induced distortions and head-motion 
displacements were corrected through affine registration of the 31 diffusion volumes to 
the first b0 volume using FSL’s Linear Registration Tool. The b-vector table (i.e., 
gradient directions) for each participant was then adjusted according to the rotation 
parameters of this linear correction. Non-brain tissue was removed using FSL’s Brain 
Extraction Tool. Fractional anisotropy (FA), an index of white matter integrity, was then 
calculated at each voxel of the brain by fitting a diffusion tensor model to the raw 
diffusion data using weighted least squares in FSL’s Diffusion Toolbox.  
The local (i.e., within-voxel) probability density functions of the principal 
diffusion direction were estimated using Markov Chain Monte Carlo sampling in FSL's 
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Bedpostx tool [15]. A spatial probability density function across voxels was then 
estimated based on these local probability density functions using FSL's Probtrackx tool 
[15], in which 5000 samples were taken for each input voxel with a 0.2 curvature 
threshold, 0.5 mm step length, and 2000 steps per sample. Segmentation of the auditory 
radiation tracts and termination masks was determined based on the MNI152 T1 brain 
provided in FSL, using FSL's FMRIB58_FA template as a DTI specific reference. MGN 
seed was defined as a R=3mm sphere centered at MNI: ±18, -26, -6.  
The primary auditory cortex seed was determined by taking the adjacent white 
matter region to the Heschl’s gyrus in the HarvardOxford cortical atlas (15). The 
termination masks excluding contralateral projections were defined MNI x<-15 (left) and 
x>+15 (right). The bilateral auditory radiation of each subject was then thresholded at a 
normalized probability value of 0.05. The mean FA within the bilateral auditory radiation 
was calculated for each individual.  
To assess the association between the auditory radiation FA and cognitive decline, 
a multiple linear regression was calculated to predict the auditory radiation FA based on 
the ADAS13 score and age. 
As secondary measures, Axial Diffusivity (AD), Radial Diffusivity (RD) and 
Mean Diffusivity (MD) were also tested. A multiple linear regression was calculated to 
predict the auditory radiation AD/RD/MD based on the ADAS13 score, age and sex. 
 
 
 
 
 
 
 7 
 
 
 
Results 
Probabilistic tractography successfully isolated the auditory radiations. In visual 
inspection, the auditory radiation of each individual subject conformed to the known 
white matter structure of the auditory radiations (Figure 1).   
The mean ADAS13 score was 15.535±8.88. In the statistical test, a significant 
regression equation was found (F(2,282)=3.03, p=0.0497), with an R2 of 0.014. The 
predicted auditory radiation FA is equal to 0.43 + 0.00058 (ADAS13) - 0.00038 (age). 
ADAS13 (p=0.021) significantly predicted the auditory radiation FA (Figure 2). 
AD but not RD or MD predicted ADAS13. Significant regression was found in 
AD, RD, and MD. ADAS significantly predicted AD but not AD and  MD. The predicted 
auditory radiation AD (F(2,282)=28.26, p<6.50e-12), with an R2 of 0.099 where the 
predicted auditory radiation AD is equal to 0.00095 + 0.0000013 (ADAS13, p=0.00055) 
+ 0.0000028 (age, p=5.82e-09). The predicted auditory radiation RD (F(2,282)=8.30, 
p=0.00031), with an R2 of 0.049 where the predicted auditory radiation RD is equal to 
0.00047 + 7.682e-8 (ADAS13, p=0.84) + 1.88e-6 (age, p=0.000087). The predicted 
auditory radiation MD (F(2,282)=16.57, p=1.5712-7), with an R2 of 0.099 where the 
predicted auditory radiation MD is equal to 0.0000063 + 4.8e-7 (ADAS13, p=0.15) + 
2.178e-6 (age, p=2.86e-7).  
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Fig 1. Probabilistic Tractography of the Auditory Radiation 
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Fig 2. Association between ADAS13 and Auditory Radiation FA 
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Fig 3. Association between ADAS13 and Auditory Radiation AD 
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Fig 4. Association between ADAS13 and Auditory Radiation RD (not significant) 
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Fig 5. Association between ADAS13 and Auditory Radiation MD (not significant) 
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Discussion 
 In this study, we tested the association between the integrity of the auditory 
radiation and cognitive decline. The FA of the auditory radiation showed positive 
association with ADAS 13 score, indicating higher white matter integrity of the auditory 
radiation in those who with more cognitive decline.  
 As evaluations to FA (fractional anisotropy), axial, radial and mean diffusivities 
were examined in their associations to ADAS 13. AD showed significant association with 
ADAS13. It is suggested that the association between FA and ADAS13 is driven by 
association between FA and ADAS13. FA is calculated in the following way, in which 
lamda1 stands for AD, lambda 2+3 for RD, lambda 1+2+3 for MD. 
 
 
 
 AD corresponds to axonal integrity. For example, reduced axial diffusivity is 
thought to reflect axonal degeneration [16], especially in white matter regions of high 
fiber coherence. Therefore, a high AD shows higher axonal integrity. Alzheimer's 
patients had a higher AD as the severity of their Alzheimer’s increased which shows that 
as the severity increases, the higher the connectivity of the auditory pathway.  
 14 
 Many studies reported increased AD in Alzheimer’s disease and early cognitive 
impairment. One study shows that axial diffusion was increased in multiple white matter 
structures, including the corpus callosum and the white matter of lateral temporal cortex, 
the posterior cingulate cortex/precuneus and the fronto-parietal regions [17]. In another 
study, patients with amnestic mild cognitive impairment (MCIa) had significantly higher 
AD in the left frontal regions of the brain, including the forceps minor and parts of the 
left prefrontal cortex, when compared to the control [18]. Further, their study also 
investigated non amnestic mild cognitive impairment (MCIna) and when compared to 
MCIa, MCIa had significantly higher AD in the left dorsal and ventral prefrontal cortex, 
including the forceps minor and uncinate fasciculus. Another study investigated the AD 
in both normal aging and in Alzheimer’s and found that AD in Alzheimer’s patients was 
higher in all six fibers except fiber bundles from the genu of the CC; whereas the normal 
old group had higher DA only in the right AIC/EC and right splenium [19]. The basis for 
these findings is unknown. However, in a study of diffusion tensor metrics, it was found 
that progressive abnormalities in the FA and RD were only seen in areas that first had an 
increase in AD and MD [20]. Therefore, they hypothesized that increased AD represents 
an upstream event that precedes neuronal loss.  
 In our study, we found that AD in the auditory radiation is associated with 
cognitive decline, assessed by ADAS13. In the study seen in [17], the criteria used to 
show the cognitive decline of Alzheimer’s patients was the Mini Mental State 
Examination (MMSE). In [18], participants’ cognition was assessed using MMSE as 
well. The study in [19] also used MMSE to determine the level of cognition of all 
participants volunteering in the study. In the study seen in [20], participants’ cognition 
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was assessed with both MMSE and Addenbrooke’s cognitive examination-revised score 
out of 100-point total (ACE-R/100). In all of the studies mentioned, the cognitive scores 
for participants with Alzheimer's or MCI showed cognitive decline, but patients with 
Alzheimer’s showed greater cognitive decline. 
 We have expected that the white matter integrity measured by FA is inversely 
associated with cognitive decline. However, our results indicated positive associations 
with them. This is surprising due to many studies that show cognition and hearing are 
positively correlated. Specifically, in one study, it was seen that all domains of cognition 
were significantly poorer in individuals with untreated hearing loss and remained poorer 
in individuals with treated hearing loss when compared to individuals with normal 
hearing [21]. Therefore, our results that showed stronger connections, via increased AD 
and FA, in the auditory pathway is surprising and it is unknown why these parameters 
increased rather than decreasing, as was predicted. However, these results were seen in 
multiple other studies.  
 Limitation of this study includes that we have no information about the status of 
hearing in these participants. In our interpretation of the results, we assumed that the 
higher FA in the auditory radiations refers to better hearing. However, we have no 
confirmatory data to support this. Further, we have no information about the participants’ 
hearing parameters before the onset of their cognitive decline and are therefore unable to 
determine if hearing differences caused Alzheimer’s disease or if Alzheimer’s disease 
caused the hearing differences seen. 
In conclusion, we found that FA and AD of the auditory radiations are positively 
associated with cognitive decline. When using ADAS13 to test for cognition, it was seen 
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that the higher the cognitive decline, the higher the FA and AD of the auditory radiation. 
Higher FA and AD correspond to a stronger connection in the primary auditory radiation 
and therefore are associated with increased hearing ability. This is surprising due to 
previous studies that suggest that higher cognitive decline is associated with increased 
hearing loss. Therefore, due to our limitations, in order to understand these results and 
determine the true relationship between hearing and cognitive ability, more studies 
should be performed. 
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Alzheimer's Disease Cooperative Study 
ADAS – Cognitive Behavior 
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   1.  WORD RECALL TASK: Indicate the total number of correct responses for each 
trial 
Trial 1:  Trial 2:  Trial 3: 
 
   2.  NAMING OBJECTS AND FINGERS: Check each object/finger named correctly or 
check "NONE.” 
 
NONE          Flower          Rattle          Wallet           Bed          Mask          Harmonica 
Whistle         Scissors           Stethoscope            Pencil           Comb         Tongs 
Thumb           Index            Ring             Pinky            Middle 
 
   3.  COMMANDS: Check each command performed       
        correctly or check “NONE.”  
NONE   
Make a fist. 
Point to the ceilinq, then to the floor. 
Put the pencil on top of the card, then put it back. 
Put the watch on the other side of the pencil and turn over the card. 
Tap each shoulder twice with two fingers keeping your eyes shut. 
 
   4.  CONSTRUCTIONAL PRAXIS: Check each figure drawn correctly. 
None: attempted but drew no forms correctly.   
Patient drew no forms; scribbled; wrote words.   
Circle 
Two overlapping rectangles    
Rhombus 
Cube 
 
   5.  IDEATlONAL PRAXIS: Check each step completed correctly or check “NONE”               
 24 
NONE   
Fold a letter. 
Put letter in envelope.  
Seal envelope.  
Address envelope. 
Indicate where stamp goes. 
 
   6.  ORIENTATION: Check each item answered correctly or check “NONE.”         
NONE   
  Full name                 Day 
 Month                 Season 
Date                      Place 
       Year                  Time of day 
 
     7.  WORD RECOGNITION TASK: Scoring will be done by the   A.D.C.S. Data 
Coordinating Center. 
 
    8.  LANGUAGE: Check level of impairment. 
None: patient speaks clearly and/or is understandable.  
Very Mild: one instance of lack of understandability. 
Mild: patient has difficulty < 25% of the time. 
Moderate: patient has difficulty 25–50% of the time. 
Moderately Severe: patient has difficulty more than 50% of the time. 
Severe: one- or two-word utterances; fluent, but empty speech; mute. 
 
   9.  COMPREHENSION OF SPOKEN LANGUAGE: Check level of impairment 
None: patient understands.  
Very Mild:  one instance of misunderstanding. 
Mild: 3–5 instances of misunderstanding. 
 25 
Moderate: requires several repetitions and rephrasing.  
Moderately Severe: patient only occasionally responds correctly; i.e., yes – no questions. 
Severe: patient rarely responds to questions appropriately; not due to poverty of speech. 
 
   10. WORD FINDING DIFFICULTY: Check one response. 
None. 
Very Mild: 1 or 2 instances, not clinically significant. 
Mild: noticeable circumlocution or synonym substitution.  
Moderate: loss of words without compensation on occasion. 
Moderately Severe: frequent loss of words without compensation. 
Severe: nearly total loss of content words; speech sounds empty; 1– to 2-word utterances.  
 
 11.  REMEMBERING TEST INSTRUCTIONS: Check level of impairment. 
None.  
Very Mild: forgets once. 
Mild: must be reminded 2 times. 
Moderate: must be reminded 3–4 times. 
Moderately Severe: must be reminded 5–6 times  
Severe: must be reminded 7 or more times. 
 
Present Word List #2. 
Check EACH word correctly recalled. 
TRIAL 1  TRIAL 2  TRIAL 3 
BOTTLE  FOREST  GIRL  
POTATO  TEMPLE  TEMPLE  
    GIRL   BOTTLE  POTATO  
      TEMPLE  STAR   ANIMAL  
   STAR   POTATO  FOREST  
 26 
      ANIMAL  GIRL   LAKE  
     FOREST  CLOCK  OFFICE  
   LAKE   ANIMAL  CLOCK  
    CLOCK  LAKE   BOTTLE  
      OFFICE  OFFICE  STAR  
   
Indicate total number of words correctly recalled for EACH trial on the ADAS Cognitive 
Behavior Form below. 
Trial 1: Trial 2: Trial 3: 
 
12. Executive Function (Maze):  
a. number of errors: 
b.   time at completion or second error (total seconds): 
 
13. Number Cancellation: 
a. number of targets hit (Range: 0 - 40): 
 b.number of errors: 
 c.number of times to remind of task: 
 
 If any item(s) 1-13 are incomplete or not done, please specify reason: 
Subject too cognitively impaired to complete 
Subject was unable to complete for physical reasons 
Subject refused 
Not Done, for reason other than above explain:  
___________________________ 
___________________________ 
___________________________ 
___________________________ 
___________________________ 
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Alzheimer's Disease Cooperative Study 
ADAS – Delayed Recall 
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Instructions:  Say to the patient, “NOW I WANT YOU TO TRY TO REMEMBER 
THE WORDS THAT I SHOWED YOU EARLIER ON PRINTED CARDS.  CAN 
YOU TELL ME ANY OF THOSE WORDS?” 
Allow a maximum of two minutes for recall. 
check EACH word correctly recalled. 
BOTTLE  
POTATO 
GIRL 
TEMPLE 
STAR 
ANIMAL 
FOREST 
LAKE 
CLOCK 
OFFICE 
TOTAL: 
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Alzheimer's Disease Cooperative Study 
ADAS – Word Recognition 
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Present Word List #2. 
Check subject's response for each word.  Subject should respond "yes" to original words which 
are bolded.  Three trials of reading and recognition are given. 
  
           Answer     Answer    Answer
COST  
NATION  
CHIMNEY  
SPARROW  
DAMAGES  
TRAFFIC  
SANDWICH  
SERVICE  
SHELL   
SOLUTION  
YARD   
TUBE   
BODY   
GROUND  
STICK   
ENGINE   
RICHES   
GRAVITY  
SUMMER  
WISDOM  
MAN   
MEAL   
PASSENGER 
ACID  
  
 
 
BATTLE   
MUCH   
TUBE   
TEAM   
COPY   
ENGINE   
GRAVITY  
COST  
JAR   
DISTANCE  
TRIUMPH  
TEMPER 
SENTENCE  
FOX 
PASSENGER 
SANDWICH 
SOLUTION 
WHISTLE 
CHIMNEY 
UNION 
ACID 
MEAL  
DAMAGES 
RICHES 
 
 
 
VISITOR  
ACID  
SPEAK   
SOLUTION  
NAME  
MEAL  
LINE  
BILL  
CHIMNEY 
ENGINE  
WEALTH  
TUBE  
IMAGE   
COST   
SANDWICH 
DAMAGES 
ELEPHANT 
RICHES   
GRAVITY 
FUTURE  
PASSENGER 
STRING   
BANNER 
BERRY 
  
Correct responses:
  
 
